The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Perifollicular Xanthomatosis as the Hallmark of Axillary Fox-Fordyce Disease: An Evaluation of Histopathologic Features of 7 Cases
Open accessAbstract
BACKGROUND: Fox-Fordyce disease (FFD) or apocrine miliaria is a rare condition with features that are characteristic clinically but not histopathologically. It is traditionally described as a condition that shows infundibular plugging, acanthosis, parakeratosis, spongiosis, and a nonspecific infiltrate. The so-called retention vesicle, which reputedly involves the apocrine duct, is often difficult to find. Recently, 4 uncontrolled observations were described (infundibular dyskeratotic cells, vacuolar alteration, cornoid lamella-like parakeratosis, and perifollicular foamy macrophages). In this study, we evaluated both established and new histopathologic criteria for the diagnosis of FFD and searched for other meaningful findings. OBSERVATIONS: Most established features were observed in both patients with FFD and control patients. All cases occurred during 1995 through 2005. No unequivocal retention vesicle was identifiable in any case. Infundibular vacuolar change and cornoid lamella-like parakeratosis were not corroborated as being diagnostically meaningful. Few dyskeratotic cells were seen in some patients with FFD and in control patients. Perifollicular foam cells were noted in most patients with FFD but not among control patients. These cells expressed CD68 but lacked expression of carcinoembryonic antigen, gross cystic disease fluid protein 15, and periodic acid-Schiff with diastase digestion. Perifollicular mucin, fibrosis, and mast cells in the infiltrate were also observed. CONCLUSIONS: The established histopathologic attributes of FFD are nonspecific, and a retention vesicle is difficult to find even in level sections. In contrast, perifollicular foam cells are a distinct, relatively consistent, and specific feature of FFD. We contend that perifollicular foam cells represent a useful hallmark of FFD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
To Err Is Human: Building a Safer Health System
(2000) · National Academies Press eBooks · doi:10.17226/9728 · Cited by 14,044
Wall, A. (2000) · British Journal of Healthcare Management · doi:10.12968/bjhc.2000.6.9.19311 · Cited by 5,903
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Robust Statistics: The Approach Based on Influence Functions
Ruppert, D. (1987) · Technometrics · doi:10.2307/1269782 · Cited by 3,880
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193
ORMSBY, O. S. (1921) · The American Journal of the Medical Sciences · doi:10.1097/00000441-192111000-00016 · Cited by 949
Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.
BEIJER, H. J. M., & Blaey, C. J. D. (2002) · Pharmacy World & Science · doi:10.1023/a:1015570104121 · Cited by 916
The Role of Medication Noncompliance and Adverse Drug Reactions in Hospitalizations of the Elderly
Col, N. F. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.841 · Cited by 794
Meyler's Side Effects of Drugs
Breckenridge, A. M. (1976) · BMJ · doi:10.1136/bmj.2.6030.307 · Cited by 691
Which drugs cause preventable admissions to hospital? A systematic review
Howard, R. L., Avery, A. J., Slavenburg, S., Royal, S., Pipe, G., Lucassen, P., & Pirmohamed, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02698.x · Cited by 625
Onder, G., Pedone, C., Landi, F., Cesari, M., Della Vedova, C., Bernabei, R., & Gambassi, G. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50607.x · Cited by 501
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study
Pouyanne, P. (2000) · BMJ · doi:10.1136/bmj.320.7241.1036 · Cited by 444
ADVERSE REACTIONS TO PRESCRIBED DRUGS IN THE ELDERLY: A MULTICENTRE INVESTIGATION
WILLIAMSON, J., & CHOPIN, J. M. (1980) · Age and Ageing · doi:10.1093/ageing/9.2.73 · Cited by 418
Reduction of Polypharmacy in the Elderly: A Systematic Review of the Role of the Pharmacist
Rollason, V., & Vogt, N. (2003) · Drugs & Aging · doi:10.2165/00002512-200320110-00003 · Cited by 361
Kramer, M. S. (1979) · JAMA · doi:10.1001/jama.1979.03300070019017 · Cited by 346
Schneeweiss, S., Hasford, J., Göttler, M., Hoffmann, A., Riethling, A.-K., & Avorn, J. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0467-0 · Cited by 274
(2007) · Choice Reviews Online · doi:10.5860/choice.44-4794 · Cited by 259
Relationship between polypharmacy and underprescribing
Kuijpers, M. A. J., Van Marum, R. J., Egberts, A. C. G., Jansen, P. A. F., & The OLDY (OLd people Drugs & dYsregulations) study group (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02961.x · Cited by 253
Howard, R. L. (2003) · Quality and Safety in Health Care · doi:10.1136/qhc.12.4.280 · Cited by 228
Hanlon, J. T., Pieper, C. F., Hajjar, E. R., Sloane, R. J., Lindblad, C. I., Ruby, C. M., & Schmader, K. E. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.5.511 · Cited by 223
Drug-Related Problems in Hospitalised Patients
van den Bemt, P. M. L. A., Egberts, T. C. G., de Jong-van den Berg, L. T. W., & Brouwers, J. R. B. J. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00005 · Cited by 202
Adverse Drug Reaction-Related Hospitalisations: A Nationwide Study in The Netherlands
van der Hooft, C. S., Sturkenboom, M. C. J. M., van Grootheest, K., Kingma, H. J., & H.Ch. Stricker, B. (2006) · Drug Safety · doi:10.2165/00002018-200629020-00006 · Cited by 186
Patel, K., Kedia, M., Bajpai, D., Ss, M., Kshirsagar, N. A., & Gogtay, N. (2007) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-7-8 · Cited by 180
James, W. D., Berger, T. G., & Elston, D. M. (2015) · Cited by 128
Emergency Department Visits Caused by Adverse Drug Events: Results of a French Survey
Queneau, P., Bannwarth, B., Carpentier, F. O., Guliana, J. M., Bouget, J., Trombert, B. A., Leverve, X. M., Lapostolle, F. D. R., Borron, S. W., & Adnet, F. (2007) · Drug Safety · doi:10.2165/00002018-200730010-00008 · Cited by 114
The molecular role of mast cells in atherosclerotic cardiovascular disease
Kelley, J., Chi, D. S., Abou-Auda, W., Smith, J. K., & Krishnaswamy, G. A. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01747-0 · Cited by 90
WALLER, P. C., Shaw, M., Ho, D., Shakir, S., & Ebrahim, S. B. J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02236.x · Cited by 74
von Euler, M., Eliasson, E., Öhlén, G., & Bergman, U. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1154 · Cited by 68
Secretion from Human Apocrine Glands: An Electron Microscopic Study
Schaumburg‐Lever, G., & Lever, W. F. (1975) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12540893 · Cited by 66
Admissions to a medical intensive care unit related to adverse drug reactions
Rivkin, A. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060641 · Cited by 61
DRUG‐RELATED HOSPITAL ADMISSIONS IN A GENERIC PHARMACEUTICAL SYSTEM
Zargarzadeh, A., Emami, M. H., & Hosseini, F. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04600.x · Cited by 45
Drug-related admissions to an inpatient psychiatric unit
Stewart, R. B., Springer, P. K., & Adams, J. E. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.9.1093 · Cited by 31
Cited by
Emergency Hospitalizations for Adverse Drug Events in Older Americans
Budnitz, D. S., Lovegrove, M. C., Shehab, N., & Richards, C. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1103053 · Cited by 1,820
Hernandez, A. F. (2010) · JAMA · doi:10.1001/jama.2010.533 · Cited by 1,032
Role of the pharmacist in reducing healthcare costs: current insights
Dalton, K., & Byrne, S. (2017) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s108047 · Cited by 449
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
Cadogan, C. A., Ryan, C., & Hughes, C. M. (2016) · Drug Safety · doi:10.1007/s40264-015-0378-5 · Cited by 298
Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions
Magro, L., Moretti, U., & Leone, R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.631910 · Cited by 287
Metadata
- Authors
- Bormate, A. B., Leboit, P. E., & McCalmont, T. H.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2008-08-01
- Volume
- 144
- Issue
- 8
- Pages
- 1020
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2108701948
- Cited by
- 731
- References
- 35
- FWCI
- 36.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.